skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Any thoughts or opinions on Mitek Systems please and thank you.
Read Answer Asked by Steve on December 09, 2020
Q: Hi Guys
I purchased a 3% position in this London based Aerospace Company for its Dividend.
The debt is a little high, but it has decent cash flow, and Interest coverage, their future earnings don't look that great at around 10%, but their ROE looked decent. What do you think ?
thanks!
Read Answer Asked by Gordon on December 09, 2020
Q: Acquisition of HyGear and a $100 million bought deal announced...thoughts?

I see there is a bought deal offering and also a private placement. Does this mean some shares will be sold to the public and some will be bought privately? With the bought deal price of $5.80, do you think the share price drops this much?

Would you add, hold or sell on this news?

Cam
Read Answer Asked by Cameron on December 09, 2020
Q: Please advice on high value stocks with good price in covid world that has good growth options in long run (2 to 5 years).
Read Answer Asked by Kapil on December 09, 2020
Q: Hi,
I am trying to look at the stocks I own , not merely as 'stocks" but rather as an investment in a good business. When I look at it that why, I am inclined not to sell indiscriminately irrespective if the stocks have gone up or not. Generally, if I do sell, I realize that I had made a terrible mistake in doing so, after the fact.
To my limited knowledge I do look to 5i for guidance.
Would you consider the stocks I have listed , to be those that represent "good businesses" and that are worth holding even 5 or 10 years out?

Thanks




Read Answer Asked by ilie on December 09, 2020
Q: Hello 5i, my question is regarding the purchase of IPF by GDNP.
Do you think it is likely that GDNP would use IPF to expand production of their own plant based products or are they just buying sales of existing IPF products. I see the huge potential of their plant based products and increased production capacity being needed.
Thank you for your help
Dave
Read Answer Asked by Dave on December 09, 2020
Q: Hi 5i guys,
I came across the ETF EDGE from Evolve that is not in your database.
It looks intriguing as a vehicle (in CDN$) to invest in global innovative/disruptive companies. Am looking at it for a small portion of my TFSA.
Also noticed that Evolve is coming out with a new ETF in the near future called DATA.
Any information/opinion on EDGE and/or an alternative in the space is appreciated.
Thanks, Steve
Read Answer Asked by STEVEN on December 08, 2020
Q: Could you please recommend a Target Date Fund or funds going out to at least 2050 that have respectable reputations with great management teams solid performance and are fairly priced.
Thank you
Read Answer Asked by Larry on December 08, 2020
Q: Hi there,

DMTK I came across DermTech listening to a MF US stock advisor live session on 10X opportunities. I spent some time reviewing their most recent earnings transcript and other research and the technology for non invasive detection of skin cancer seems powerful but super early in terms of adoption (a brief excerpt is below). I am considering buying for TFSA and have the following questions:
1. What is your general opinion?
2. Do you have any information on how a dermatologist would be paid for using this test vs surgery? My fear would be that the tech is amazing but dermatologists may not use it if it would reduce their revenue

"Currently, approximately 25 surgical biopsies are performed to find one melanoma. And despite all this cutting, the negative predictive value of this pathway is only about 83%, which means the probability of missing melanoma is approximately 17%. The PLA reduces the number of surgical biopsies needed to identify melanomas by approximately 10-fold and increases the negative predictive value so 99%, meaning the PLA has less than 1% probability of missing the disease. DermTech is effectively bringing melanoma diagnosis into the 21st century by transforming it from a pathway to subjective, invasive, inaccurate and costly to one that is objective, non-invasive, highly accurate, and less costly."
Read Answer Asked by Tim on December 08, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!